Herbalife Exceeds 2025 Guidance with Ronaldo-Backed Pro2col Investment
Event summary
- Herbalife reported Q4 2025 net sales of $1.3B, up 6.3% YoY, exceeding guidance.
- Full-year 2025 net sales reached $5B, up 0.9% YoY, with adjusted EBITDA at $657.6M.
- Cristiano Ronaldo invested $7.5M for a 10% stake in Pro2col Software in February 2026.
- Pro2col Beta 2.0 launched in December 2025, expanding beta access to U.S., Canada, and Puerto Rico.
- Herbalife maintained a total leverage ratio of 2.8x at year-end 2025.
The big picture
Herbalife's strong 2025 financial performance, coupled with Ronaldo's strategic investment, underscores the company's push into AI-driven personalized nutrition. The focus on digital transformation and global scaling aligns with broader industry trends toward data-driven wellness solutions. With Pro2col at the forefront, Herbalife aims to redefine the health and wellness market, leveraging celebrity endorsement and technological innovation to drive growth.
What we're watching
- Strategic Scaling
- How Herbalife will leverage Ronaldo's investment to accelerate Pro2col's global expansion.
- Market Penetration
- Whether the Pro2col Beta 2.0 rollout will drive sustained distributor and customer growth.
- Financial Discipline
- The pace at which Herbalife can maintain its leverage ratio while funding digital and product innovation.
Related topics